NEWS
Tanning Bed Study Shows Strongest Evidence Yet of Increased Melanoma Risk
In perhaps the strongest epidemiologic research of its kind to date, a case-control study of invasive cutaneous melanoma, involving more than 2,200 participants, found that any use of indoor tanning devices increased melanoma risk, but the risk was highest among those who engaged in indoor tanning most frequently. The findings were published online May 27 in Cancer Epidemiology Biomarkers and Prevention. Read more > >
Some Older Women Can Forgo Radiation after Breast Cancer Surgery
Radiation therapy after breast-conserving surgery for early-stage cancer does not improve survival for women 70 or olderSorafenib Kills Malignant Glioma Cells by Blocking Vital Cell Survival Pathway
In vitro experiments also find synergy with commonly used chemotherapy for brain cancerGenome Study Profiles Aggressive Form of Breast Cancer
Uncommon variants may distinguish triple-negative tumors from other typesShark Cartilage Extract Ineffective Against Lung Cancer
Rigorous study finds no benefit for patients
COMMENTARY
Director's Update: In a Time of Transition, a Strong Foundation for Success
As the outgoing director of the National Cancer Institute, I would like you to know how honored I am to have been asked to serve in this wonderful position. Virtually every day brings a fresh reminder of the privilege and excitement that stem from being part of an extraordinary history of biomedical research. Since 1937, when it became the first disease-based institute of what would become the National Institutes of Health, thousands of women and men have devoted their professional lives to NCI and to alleviating the burden of cancer for all who suffer its pain. Read more > >
A Conversation with Drs. Deborah Winn and Shelia Zahm about Environmental Cancer Risks
The deputy directors of NCI’s Division of Cancer Control and Population Sciences and Division of Cancer Epidemiology and Genetics discuss environmental risk research. Read more > >
A MESSAGE TO READERS
Coverage of ASCO Annual Meeting
The American Society of Clinical Oncology Annual Meeting will take place June 4-8 in Chicago. Look for highlights from the meeting in the June 15 issue of the NCI Cancer Bulletin. Please also visit the NCI@ASCO Web site to learn about NCI events during the meeting.
IN DEPTH
Spotlight: The Test and the Target: Diagnostics’ Critical Role in Individualized Cancer Care
Companion tests to targeted therapies beginning to emerge as research, clinical priorities
Profiles in Cancer Research: Dr. Sholom Wacholder
NCI Senior Investigator embraces challenge of biostatistics in cancer research
Cancer Center Profile: UCLA Jonsson Comprehensive Cancer Center
Since the 1960s, UCLA cancer center has strived for excellence in research, education, and patient care
Featured Clinical Trial: Targeting the Hedgehog Pathway in Stomach Cancer
Can adding a Hedgehog inhibitor improve chemotherapy for advanced stomach cancer?
UPDATES
Notes
- As Summer Begins, National Organization Helps Highlight Dangers of UV Overexposure
- Meet NCI Experts at ASCO (Updated)
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit .
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
